Paul Ehrlich Institute

Langen, Germany Founded: 1896 • Age: 130 yrs
Drug research, development, pharmacovigilance, and regulatory support are provided.

About Paul Ehrlich Institute

Paul Ehrlich Institute is a Healthcare company based in Langen (Germany) founded in 1896. Drug research, development, pharmacovigilance, and regulatory support are provided. Its website pei.de draws about 132 thousand monthly visits. Paul Ehrlich Institute offers products and services including Vaccine Testing, Pharmaceutical Regulation, and Batch Prüfung. Its focus areas include Biopharma Outsourcing and Diversified. Its legal entity is Paul-Ehrlich-Institut.

Company details

The Paul Ehrlich Institute was established in 1896 and is based in Langen, Germany. Operations are centered on the pharmaceutical and biomedical sectors, where drug research and development are conducted alongside pharmacovigilance monitoring. Regulatory support services are extended to ensure compliance and safety in vaccine and biomedicine fields. Expertise is applied through federal oversight, focusing on public health standards across European contexts.

  • Headquarters Langen, Germany
  • Sectors
    Healthcare
  • Website category Health · Pharmacy
  • Website pei.de/DE/home/home-node.html
  • Legal Name Paul-Ehrlich-Institut
Key Metrics

Products & Services of Paul Ehrlich Institute

Paul Ehrlich Institute offers a comprehensive portfolio of products and services, including Vaccine Testing, Pharmaceutical Regulation, and Batch Prüfung.

Vaccine Testing
Regulatory Services

Tests vaccines for quality, efficacy, and safety standards.

Pharmaceutical Regulation
Oversight Services

Monitors and approves medicines for public health compliance.

Batch Prüfung
Testing Services

Evaluates drug batches for regulatory adherence and safety.

Funding Insights of Paul Ehrlich Institute

  • Total Rounds 5
  • First Round $411,826

    (Jan 2018)

  • Investors Count 1

All 5 funding rounds of Paul Ehrlich Institute with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2023Grant––
Feb 2021Grant––
Mar 2020$558,772Grant––
May 2018$275,268Grant––
Jan 2018$411,826Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Paul Ehrlich Institute

Paul Ehrlich Institute has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Paul Ehrlich Institute

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Paul Ehrlich Institute

3 dated milestones of Paul Ehrlich Institute across 127 years, from founding to its latest funding, stage changes and deals.

  1. Founded Paul Ehrlich Institute is founded.
  2. Funding First funding round of $412K.
  3. Funding Latest funding round, Grant,.

Web traffic of Paul Ehrlich Institute

The website of Paul Ehrlich Institute (pei.de) receives about 132.3K visits a month and ranks #350,606 among all websites worldwide, #661 in Pharmacy.

  • Monthly visits
    132.3K

    ▲ 6.8% vs previous month

  • Unique visitors
    69.7K

    per month

  • Global rank
    #350,606

    among all websites

  • Category rank
    #661

    Health · Pharmacy

Similar websites

Websites whose visitors overlap most with Paul Ehrlich Institute. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
apotheke-adhoc.de
apotheke-adhoc.de
100%
#29,969–
portal.dimdi.de
portal.dimdi.de
94%
–
rki.de
92%
911.4K#68,633View details
gelbe-liste.de
90%
#27,850View details
fachinfo.de
fachinfo.de
85%
#186,542–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Paul Ehrlich Institute

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Paul Ehrlich Institute

Paul Ehrlich Institute was founded in 1896 and raised its 1st funding round 122 years after it was founded.

Paul Ehrlich Institute is headquartered in Langen, Germany. It is registered at Langen, Hesse, Germany.

The Paul Ehrlich Institute was established in 1896 and is based in Langen, Germany. Operations are centered on the pharmaceutical and biomedical sectors, where drug research and development are conducted alongside pharmacovigilance monitoring. Regulatory support services are extended to ensure compliance and safety in vaccine and biomedicine fields. Expertise is applied through federal oversight, focusing on public health standards across European contexts.

Paul Ehrlich Institute offers Vaccine Testing, Pharmaceutical Regulation, and Batch Prüfung.

Paul Ehrlich Institute has 1 investor. Key investors include European Union.

Paul Ehrlich Institute operates through Paul-Ehrlich-Institut.

The website of Paul Ehrlich Institute receives about 132 thousand visits a month and ranks #350,606 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available